Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Thorn

Showing results (41-50 of 148) with videos related to

Pageof 15
Sort By:
Psychoneuroendocrinology|June 5, 2004
The effect of dawn simulation on the cortisol response to awakening in healthy participantsL Thorn, F Hucklebridge, A Esgate, et al.
Psychoneuroendocrinology|February 8, 2019
Salience versus magnitude in the measurement of the cortisol awakening responseP Evans, N Smyth, L Thorn, et al.
Stress (Amsterdam, Netherlands)|July 28, 2011
Differences between diurnal patterns of salivary cortisol and dehydroepiandrosterone in healthy female adolescentsA Oskis, A Clow, L Thorn, et al.
Psychoneuroendocrinology|October 28, 2008
Diurnal patterns of salivary cortisol across the adolescent period in healthy femalesA Oskis, C Loveday, F Hucklebridge, et al.
European Journal of Pharmacology|November 3, 1994
Competitive NMDA receptor antagonists attenuate the behavioural and neurochemical effects of amphetamine in miceL J Bristow, L Thorn, M D Tricklebank, et al.
British Journal of Pharmacology|April 1, 1993
The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodentsL J Bristow, P H Hutson, L Thorn, et al.
British Journal of Pharmacology|August 1, 1991
R-(+)-HA-966, a glycine/NMDA receptor antagonist, selectively blocks the activation of the mesolimbic dopamine system by amphetamineP H Hutson, L J Bristow, L Thorn, et al.
Neuropharmacology|June 1, 1997
Evidence to suggest that agonist modulation of hyperlocomotion is via post-synaptic dopamine D2 or D3 receptorsL Thorn, T E Ashmeade, V J Storey, et al.
Peptide Research|November 1, 1988
Generation and characterization of specific antibodies directed to the binding domain of adhesive moleculesS A Berliner, J R Roberts, M L Thorn, et al.
The Journal of Nutrition|April 7, 2026
The Ins and Outs of Manganese: ZIP14 facilitates manganese efflux from the mouse brainJ Zou, T L Thorn, Z Wang, et al.
Pageof 15

Showing results (41-50 of 148) with videos related to

Sort By:
Pageof 15
Psychoneuroendocrinology|June 5, 2004
The effect of dawn simulation on the cortisol response to awakening in healthy participantsL Thorn, F Hucklebridge, A Esgate, et al.
Psychoneuroendocrinology|February 8, 2019
Salience versus magnitude in the measurement of the cortisol awakening responseP Evans, N Smyth, L Thorn, et al.
Stress (Amsterdam, Netherlands)|July 28, 2011
Differences between diurnal patterns of salivary cortisol and dehydroepiandrosterone in healthy female adolescentsA Oskis, A Clow, L Thorn, et al.
Psychoneuroendocrinology|October 28, 2008
Diurnal patterns of salivary cortisol across the adolescent period in healthy femalesA Oskis, C Loveday, F Hucklebridge, et al.
European Journal of Pharmacology|November 3, 1994
Competitive NMDA receptor antagonists attenuate the behavioural and neurochemical effects of amphetamine in miceL J Bristow, L Thorn, M D Tricklebank, et al.
British Journal of Pharmacology|April 1, 1993
The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodentsL J Bristow, P H Hutson, L Thorn, et al.
British Journal of Pharmacology|August 1, 1991
R-(+)-HA-966, a glycine/NMDA receptor antagonist, selectively blocks the activation of the mesolimbic dopamine system by amphetamineP H Hutson, L J Bristow, L Thorn, et al.
Neuropharmacology|June 1, 1997
Evidence to suggest that agonist modulation of hyperlocomotion is via post-synaptic dopamine D2 or D3 receptorsL Thorn, T E Ashmeade, V J Storey, et al.
Peptide Research|November 1, 1988
Generation and characterization of specific antibodies directed to the binding domain of adhesive moleculesS A Berliner, J R Roberts, M L Thorn, et al.
The Journal of Nutrition|April 7, 2026
The Ins and Outs of Manganese: ZIP14 facilitates manganese efflux from the mouse brainJ Zou, T L Thorn, Z Wang, et al.
Pageof 15